Actively Recruiting
FRAME Study: Retrograde Nailing Versus Open Reduction and Internal Fixation for Unstable Ankle Fractures in Frail Older Adults - A Two-Part Multi-Center Randomized Clinical Trial
Led by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Updated on 2026-01-28
172
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are conducting a multi-center randomized controlled trial to compare treatment options for elderly patients with complex or unstable ankle fractures. The study aims to evaluate primary ankle fusion versus open reduction and internal fixation (ORIF) in frail older adults, especially those with significant co-morbidities or compromised soft tissue. The trial explores whether primary ankle fusion or retrograde intramedullary fibular nailing can improve outcomes like pain, function, and complication rates compared to ORIF. Participants will be assigned to one of two parts of the trial based on the fracture complexity. In part 1, patients with severe fractures will receive either a retrograde tibio-talar-calcaneal hindfoot nail for primary ankle fusion or ORIF using modern fixation techniques. In part 2, patients with less complex but unstable fractures will be assigned to receive either retrograde intramedullary fibular nailing (IMFN) or ORIF. The procedures involve specialized surgical techniques tailored to each group. Participants will be followed for at least one year after surgery, with assessments including questionnaires on quality of life, pain, and function, as well as physical tests and complication tracking. Data will be collected during clinic visits and through phone or email contact. Some participants may be contacted at five years for long-term outcome evaluation. The primary outcome measure is the Short-Form 12 health survey at one year post-surgery.
CONDITIONS
Brief Title
FRAME Study (Frailty-Related Ankle Fracture Management and Evaluation)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 60 years or older
- Severe soft tissue compromise or significant co-morbidities such as vascular disease with chronic changes, diabetes with neuropathy, chronic renal failure, or morbid obesity (BMI > 40)
- Frailty with a clinical frailty scale score of 4 or higher
- For part 1: Isolated severe fracture within 4 weeks of injury, tibial pilon AO/OTA type 43C2 or C3 or severe ankle fracture (dislocation, joint impaction, trimalleolar)
- For part 2: Isolated less complex unstable fracture within 4 weeks of injury, AO/OTA type 44B2, B3, C1, or C2 ankle fracture
You will not qualify if you...
- Presence of vascular injury or pathologic fracture
- Previous tibia pilon fracture or retained hardware in the affected limb
- Refusal to participate in the study
- Inability to give informed consent due to language barriers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 4 weeks from injury
Participants receive surgical treatment for their ankle fractures, either primary ankle arthrodesis (fusion), intramedullary fibular nailing (IMFN), or open reduction and internal fixation (ORIF).
1 surgical procedure visit
Duration - Up to 1 year post-surgery
Participants are followed up to assess recovery, complications, pain, and functional outcomes through clinic or hospital visits and contact via phone or email.
Regular visits and contacts over 1 year
Duration - Up to 5 years post-surgery
Participants who consent may be contacted at 5 years post-surgery to evaluate long-term changes in outcomes.
Contact via phone or email as consented
Trial Site Locations
Total: 1 location
1
London Health Sciences Centre
London, Ontario, Canada, N6A5W9
Actively Recruiting
Research Team
E
Emil Schemitsch, MD, FRCS(C)
A
Abdel Lawendy, MD, FRCS(C)
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here